Panadol is owned by Haleon (the United Kingdom, LSE: HLN), which was separated from GSK on 18 July 2022.[1][2] Before Haleon, Panadol was owned by GSK from 2000 to 2022.[2]
Evidence: Haleon plc Annual Report on Form 20-F filed 2026-03-13, SEC EDGAR, 13 March 2026. Verified from filings; last checked .
Panadol is a paracetamol brand launched in Britain in 1956 and sold across Europe, Asia, Africa and Australia. It occupies the position outside the United States that Tylenol holds within it, and the two are the same active ingredient under different names.
Sentences about Panadol from Haleon's latest annual filing[1], copied word for word.
Organic growth was driven by mid-single digit growth in Panadol underpinned by continued share gains in a number of markets including UK and Australia.
Growth was supported by innovation including Panadol Dual Action, a paracetamol and ibuprofen combination product which leverages the technology in Advil.
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named less often than it was three years earlier.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Haleon ownership tree →
See the full Haleon brand portfolio (8) →
Haleon controls 8 brands on Brandtree, 4 of them in consumer health.
Haleon has more brands in pain relief on Brandtree than any other owner: 3 of 37.
| Brand | Owner | Owner based in |
|---|---|---|
| Air Salonpas | Hisamitsu Pharmaceutical | 🇯🇵 Japan |
| Motrin | Kenvue | 🇺🇸 United States |
| Dafalgan | Taisho Pharmaceutical | 🇯🇵 Japan |
| Nicotex | Cipla | 🇮🇳 India |
| Mentho Plus | Emami | 🇮🇳 India |
| Bufferin (United States) | Genomma Lab | 🇲🇽 Mexico |
| Doril | Hypera | 🇧🇷 Brazil |
| Daleron | Krka | 🇸🇮 Slovenia |
Haleon is a publicly listed company headquartered in Weybridge, United Kingdom, founded in 2022. Brandtree records 8 brands under its control, and it is listed as LSE: HLN and NYSE: HLN.
Haleon is the consumer health business demerged from GSK in July 2022, having earlier absorbed Pfizer's consumer health portfolio through a joint venture. It is the largest standalone consumer health company in the world, built on oral health, pain relief, respiratory health and vitamins.
Brandtree records a controlling owner for 552 brands that began in the United Kingdom. 291 of them (53%) are now controlled by a company headquartered in another country; Panadol is not one of them.
GSK demerged its consumer healthcare business as Haleon, listing it in London and New York in July 2022. The business already contained Pfizer's consumer health portfolio, contributed to a joint venture in 2019, which is how Advil and Centrum came to sit alongside Sensodyne and Panadol.
The parent company of Panadol is Haleon, a publicly listed company headquartered in the United Kingdom.
Yes. Panadol originated in the United Kingdom in 1956 and its owner, Haleon, is also headquartered in the United Kingdom.
Haleon has owned Panadol since 18 July 2022.
Before Haleon, Panadol was owned by GSK from 2000 until 2022.
Yes. As of 9 October 2026, Panadol is still owned by Haleon. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy